Xeltis raised €19M in a funding round in Jul 2026. The company is based in Zurich, Switzerland. Investors in the round: DaVita, EQT Life Sciences, European Innovation Council (EIC) and 4 others. Data as of 15 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
